People

Peter Smith

Peter Smith, also published as Pete Smith, is co-founder, president and CEO of Remix Therapeutics and an Atlas adviser. His biography describes earlier scientific leadership at H3 Biomedicine and oncology drug discovery at Takeda and Millennium. He completed a Newcastle University PhD and postdoctoral research at Dana-Farber. He is distinct from the EQT infrastructure investor with the same name.